Suchergebnisse - "WU LINGYUN"

PubPharm (625)

1

SALT FORM OF PYRROLOTRIAZINE COMPOUND, CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | WEI XIAWEI | YOU XU | +3

2

Corrigendum to 'Osteopontin modulates microglial activation states and attenuates inflammatory responses after subarachnoid hemorrhage in rats' [Experimental Neurology 371 (2024) 114585

enthalten in: Experimental neurology | 2024

von Sun, C. | Rahman, M. | Enkhjargal, B. | +10

ErratumFor: Exp Neurol. 2024 Jan;371:114585. - PMID 37884185

3

Raman lidar at 355 nm using low dead time photon counting for atmospheric aerosol measurements

enthalten in: Applied optics | 2024

von Chen, F. | Wu, L. | Chen, C. | +14

4

벤조옥사지논 유도체

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | XIAO ZHEMING | CHEN YI | +8

5

OXADIAZOLE-SUBSTITUTED SPIROCYCLIC COMPOUND AND APPLICATION THEREOF

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | YOU XU | ZHAO LELE | +1

6

OXADIAZOLE-SUBSTITUTED SPIROCYCLIC COMPOUND AND APPLICATION THEREOF

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | YOU XU | ZHAO LELE | +1

7

6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | DAI TIANZI | ZHAO LELE | +4

8

6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES

enthalten in: Europäisches Patentamt | 2024

von WU LINGYUN | DAI TIANZI | ZHAO LELE | +4

9

Dynamics of SARS-CoV-2 IgG antibodies and neutralising antibodies in rheumatic and musculoskeletal diseases patients with COVID-19

enthalten in: Clinical and experimental rheumatology | 2024

von Wang, Q. | Wu, Y. | Wu, L. | +6

10

The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus

enthalten in: ResearchSquare.com | 2024

von Xu, F. | Jin, J. | Guo, J. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[63]